0001209191-11-031081.txt : 20110525 0001209191-11-031081.hdr.sgml : 20110525 20110525201410 ACCESSION NUMBER: 0001209191-11-031081 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110523 FILED AS OF DATE: 20110525 DATE AS OF CHANGE: 20110525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KRUMEL CAROLINE J CENTRAL INDEX KEY: 0001511233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 11872347 MAIL ADDRESS: STREET 1: C/O 932 SOUTHWOOD BOULEVARD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-05-23 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001511233 KRUMEL CAROLINE J 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451 0 1 0 0 Vice President of Finance Common Stock 2011-05-23 4 A 0 4583 0.00 A 4583 D The shares will vest on December 31, 2012, provided Ms. Krumel is continuously employed by the Company through such date. In the event Ms. Krumel is terminated by PDL without cause or resigns for good reason, the shares shall ratably accelerate and vest in proportion to the time lapsed during the vesting period. During the vesting period, Ms. Krumel has the right to vote the shares and will receive any dividends and other shareholder distributions paid by PDL. Such dividends and other distributions shall accumulate with interest and will vest and pay if and when the underlying shares vest. /s/ Danny J Hart, Jr., Attorney-in-Fact for Caroline J. Krumel 2011-05-25